Replacement of carvedilol for propranolol in patients with heart failure;Substituição do carvedilol pelo propranolol em pacientes com insuficiência cardíaca

Arquivos Brasileiros de Cardiologia

Volumn 95, Issue 1, 2010, Pages 107-114

  Marques, Fabiana ^a   De Castro, Renato Barroso Pereira ^a   Nobre, Fernando ^a   Pintya, Antonio Osvaldo ^a   Gallo Jr , Lourenço ^a   Maciel, Benedito Carlos ^a   Simões, Marcus Vinícius ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Betablocker; Heart failure; Propranolol

Indexed keywords

CAPTOPRIL; CARVEDILOL; DIGOXIN; ENALAPRIL; FUROSEMIDE; PROPRANOLOL; SPIRONOLACTONE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DRUG FATALITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL STATUS; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HOLTER MONITORING; HUMAN; MALE; PATIENT ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; RADIOISOTOPE VENTRICULOGRAPHY; SYSTOLIC BLOOD PRESSURE;

EID: 77956855845     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000062     Document Type: Article

References (26)

1. Waagstein F, Hjalmarson A C, Wasir HS. Apex cardiogram and sistolic time intervals in acute myocardial infarction and effects of practolol. Br Heart J. 1974; 36 (11): 1109-21. [Links]
2. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975; 37 (10): 1022-36. [Links]
3. Packer M, Bristow MR, Cohn JN, Collucci W, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U S Carvedilol Heart Failure Study Group. N Engl J Med. 1996; 334 (21): 1349-55. [Links]
4. Packer M, Coats AJS, Fowler MB, katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001; 344 (22): 1651-8. [Links]
5. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999; 353 (9169): 2001-7. [Links]
6. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet. 1999; 353 (9146): 9-13. [Links]
7. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005; 26 (3): 215-25. [Links]
8. Tavares LR, Victer H, Linhares JM, Barros CM, Oliveira MV, Pacheco LC, et al. Epidemiology of decompensated heart failure in the city of Niterói - EPICA - Niterói Project. Arq Bras Cardiol. 2001; 82 (2): 125-8. [Links] (Pubitemid 38391303)
9. Waagstein F, Caidahl K, Wallentin I, Berg C, Hjalmaroson A. Long-term beta-blockade in dilated cardiomyopathy: effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation. 1989; 80 (3): 551-63. [Links] (Pubitemid 19231389)
10. van Campen LCMC, Visser F, Visser CA. Ejection fraction improvement by V-blocker treatment in patients with heart failure: an analysis of studies published in the literature. J Cardiovasc Pharmacol. 1998; 32 (1): S31-5. [Links] (Pubitemid 28415089)
11. Maia ER, Villacorta H, Subietta GC, Munhoz C, Romeu-Filho LJM, Mesquita ET. Use of propranolol in heart failure patients: safety, tolerability, and effects on left ventricular function. Rev Port Cardiol. 2001; 20 (4): 383-99. [Links]
12. Talwar KK, Bhargava B, Upasani PT, Verma S, Kamlakar T, Chopra P. Hemodynamic predictors of early intolerance and long-term effects of propranolol in dilated cardiomyopathy. J Card Fail. 1996; 2 (4): 273-7. [Links] (Pubitemid 126666365)
13. Chadda KK, Goldstein S, Byington R, Curb JD. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 1986; 73 (3): 503-10. [Links] (Pubitemid 16133029)
14. Mckee PA, Castelli WP, Mcnamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971; 285: 1441-6. [Links]
15. ATS Committe on proficiency standards for clinical pulmonary function laboratories. ATS statement: guidelines for the six-minute walk test. Am J Crit Car Med. 2002; 166 (1): 111-7. [Links]
16. Flannery G, Gehrig-Mills R, Billah B, Krum H. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Am J Cardiol. 2008; 101 (6): 865-9. [Links]
17. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993; 342 (8885): 1441-6. [Links]
18. A randomized trial of beta-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation. 1994; 90 (4): 1765-73. [Links]
19. De Mey C, Breithaupt-Grogler K, Schloos J, Palm D, Belz GG. Reproducibility and consistency of the responses to supine bicycle ergometry: evaluation in conjunction with V-1 adrenoreceptor occupancies. Br J Clin Pharm. 1994; 38 (5): 480-3. [Links]
20. Chidsey CA, Morselli P, Bianchetti G, Marganti A, Leonetti G, Zanchetti A. Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation. 1975; 52 (2): 313-8. [Links]
21. Talwar KK, Bhargava B, Upasani PT, Verma S, Kamlakar T, Chopra P. Hemodynamic predictors of early intolerance and long-term effects of propranolol in dilated cardiomyopathy. J Card Fail. 1996; 2 (4): 273-7. [Links] (Pubitemid 126666365)
22. Gilbert EM, Abraham WT, Olsen S, Hattler B, White M Mealy P, Larrabee P, et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 1996; 94 (11): 2817-25. [Links] (Pubitemid 26411746)
23. Bilchick KC, Fetics B, Djoukeng R, Fisher SG, Fletcher RD, Singh SN, et al. Prognostic values of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol. 2002; 90 (1): 24-8. [Links] (Pubitemid 34671197)
24. Galinier M, Pathak A, Fourcade J, Androdias C, Curnier D, Varnous S, et al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J. 2000; 21 (6): 475-82. [Links] (Pubitemid 30122135)
25. Malfatto G, Facchini M, Branzi G, Riva B, Sala L, Perego GB. Long-term treatment with the beta-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failure. J Cardiovasc Pharmacol. 2003; 42 (1): 125-31. [Links] (Pubitemid 36791360)
26. Mortara A, La Rovere MT, Pinna GD, Maestri R, CapomollaS, Cobelli F. Nonselective beta adrenergic blocking agent carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol. 2000; 36: 1612-8. [Links]